212 Combat Support Hospital: Minimizing Opioid Use through Multimodal Analgesia
The 212th CSH is composed of a tightly knit group of nurses, physicians, anesthesia providers, medics and support personnel. This continuing education program is a vital part of maintaining the level of excellence expected and needed in our function as a field hospital. While our optempo is high, much of our workload is necessarily focused on non-medical tasks. As such LPNs and medics within the CSH have limited access to direct patient care experiences and furthering education. These are vital in achieving the level of expertise necessary to providing life-saving damage control medical attention in a deployed setting and austere environment we would be expected to provide if we are activated and deployed. Through engaging didactic seminars led by subject matter experts, and hands on high fidelity simulation we will elevate our medical personnel’s understanding of, and capacity for their profession. These soldiers will be trained to meet the demand of life-saving trauma management required in deployed situations.
Target Audience
This CE activity is accredited by the DHA J-7 Continuing Education Program Office (CEPO). This activity provides continuing education for physicians, physician assistants, psychologists, nurses, and counselors. A certificate of attendance is available for other attendees.
Learning Objectives
- Select non-opioid pain medications based on a patient’s presenting severity of pain and comorbidities
- Identify the considerations and limitations for use of common peripheral nerve blocks and nerve catheters.
- Explain the role and limitations of liposomal bupivacaine in peripheral nerve blocks.
Garrett Jackson, MD. The presenter has no financial or non-financial relationships to disclose.
Available Credit
- 1.00 Physician Assistants (AAPA)DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 hours of AAPA Category 1 CME credits. Approval is valid until Friday, November 29, 2019 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
- 1.00 Physicians (ACCME)
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Psychologists (APA)Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). DHA, J7, CEPO maintains responsibility for the content of the programs. DHA, J-7, CEPO designated this activity for a maximum of 1.00 CE credits. The instructional level of this activity is intermediate. There is no cost to participate.
- 1.00 Certificate of Attendance
- 1.00 Interprofessional Continuing Education (IPCE)
In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
- 1.00 Certified Counselors (NBCC)
DHA, J-7, Continuing Education Program Office (CEPO) has been approved by National Board for Certified Counselors (NBCC) as an Approved Continuing Education Provider, ACEP No. . Programs that do not qualify for National Board of Certified Counselors (NBCC) credit are clearly identified. DHA, J-7, CEPO is solely responsible for all aspects of the programs.